Lantern Pharma Inc. SEC filings LTRN
Lantern Pharma Inc. has 262 filings in SEC EDGAR's recent list, going back to Jan 14, 2019. Its latest annual report, Form ARS, was filed on Oct 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 1, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 30, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 14, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2025 | Sep 19, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jul 29, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 24, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2023 | Dec 29, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 24, 2023 | Nov 21, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Oct 20, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 20, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2023 | Jan 12, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 3, 2022 | May 3, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 26, 2022 | Apr 20, 2022 |
| 8-K |
Current report
Other events
|
Apr 25, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Other events
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Other events
|
Jan 24, 2022 | Jan 24, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2021 | Nov 22, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 1, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2021 | May 19, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 3, 2021 | May 3, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2021 | Mar 10, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 6, 2021 | Dec 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2020 | Aug 19, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 16, 2020 | Jul 10, 2020 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jun 17, 2020 | Jun 11, 2020 |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LTRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1763950
- Former names
- Lantern Pharma (until Jan 14, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.